Suppr超能文献

泛素E3连接酶SCF和APC/C在人类癌症中的重要性。

The Importance of Ubiquitin E3 Ligases, SCF and APC/C, in Human Cancers.

作者信息

Bochis Ovidiu Vasile, Fetica Bogdan, Vlad Catalin, Achimas-Cadariu Patriciu, Irimie Alexandru

机构信息

Department of Medical Oncology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Department of Pathology, "Prof. Dr. Ion Chiricuta" Institute of Oncology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

出版信息

Clujul Med. 2015;88(1):9-14. doi: 10.15386/cjmed-377. Epub 2015 Jan 28.

Abstract

A normal evolution of the cell-cycle phases consists of multiple consecutive events, which makes it a highly complex process. Its preservation is regulated by Cyclin-Cdks (cyclin-dependent kinases) interactions and protein degradation, which is often controlled by the ubiquitin-mediated proteolysis. The goal of this review is to emphasize the most important features of the regulation of the cell-cycle involved in cancerogenesis, by presenting the involvement of E3 ubiquitin ligases SCF (Skp1-Cul1-F-box protein) and APC/C (Anaphase-promoting complex/cyclosome) in human malignancies. Also, we discuss the importance of the ubiquitin proteasome pathway blockade in cancer treatment. We know that a better understanding of the regulatory biology of the cell cycle can lead to the development of new target therapies for cancer.

摘要

细胞周期各阶段的正常演变由多个连续事件组成,这使其成为一个高度复杂的过程。其维持由细胞周期蛋白 - 细胞周期蛋白依赖性激酶(Cyclin - Cdks)相互作用和蛋白质降解来调节,而这通常由泛素介导的蛋白水解控制。本综述的目的是通过阐述E3泛素连接酶SCF(Skp1 - Cul1 - F - box蛋白)和后期促进复合物/细胞周期体(APC/C)在人类恶性肿瘤中的作用,强调参与肿瘤发生的细胞周期调控的最重要特征。此外,我们还讨论了泛素蛋白酶体途径阻断在癌症治疗中的重要性。我们知道,更好地理解细胞周期的调控生物学可以推动癌症新靶向治疗方法的开发。

相似文献

1
The Importance of Ubiquitin E3 Ligases, SCF and APC/C, in Human Cancers.
Clujul Med. 2015;88(1):9-14. doi: 10.15386/cjmed-377. Epub 2015 Jan 28.
2
The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.
Biochim Biophys Acta. 2014 Jan;1843(1):150-62. doi: 10.1016/j.bbamcr.2013.02.028. Epub 2013 Mar 1.
3
Ubiquitin ligases: cell-cycle control and cancer.
Nat Rev Cancer. 2006 May;6(5):369-81. doi: 10.1038/nrc1881.
4
The APC/C Ubiquitin Ligase: From Cell Biology to Tumorigenesis.
Front Oncol. 2012 Jan 9;1:60. doi: 10.3389/fonc.2011.00060. eCollection 2011.
5
SCF and APC: the Yin and Yang of cell cycle regulated proteolysis.
Curr Opin Cell Biol. 1998 Dec;10(6):759-68. doi: 10.1016/s0955-0674(98)80119-1.
7
Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin.
Trends Cell Biol. 2020 Aug;30(8):640-652. doi: 10.1016/j.tcb.2020.05.002. Epub 2020 Jun 5.
8
Structure, function and mechanism of the anaphase promoting complex (APC/C).
Q Rev Biophys. 2011 May;44(2):153-90. doi: 10.1017/S0033583510000259. Epub 2010 Nov 22.
9
Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.
Nature. 2004 Mar 11;428(6979):190-3. doi: 10.1038/nature02330.
10
The anaphase-promoting complex: a key factor in the regulation of cell cycle.
Oncogene. 2005 Jan 13;24(3):314-25. doi: 10.1038/sj.onc.1207973.

引用本文的文献

1
Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
BMC Cancer. 2020 Oct 28;20(1):1037. doi: 10.1186/s12885-020-07529-2.
4
WD40 domain of Apc1 is critical for the coactivator-induced allosteric transition that stimulates APC/C catalytic activity.
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10547-52. doi: 10.1073/pnas.1607147113. Epub 2016 Sep 6.
5
FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
Tumour Biol. 2016 Oct;37(10):14311-14319. doi: 10.1007/s13277-016-5298-1. Epub 2016 Sep 5.

本文引用的文献

1
p27 is regulated independently of Skp2 in the absence of Cdk2.
Biochim Biophys Acta. 2014 Feb;1843(2):436-45. doi: 10.1016/j.bbamcr.2013.11.005. Epub 2013 Nov 21.
2
The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer.
Biochim Biophys Acta. 2014 Jan;1843(1):150-62. doi: 10.1016/j.bbamcr.2013.02.028. Epub 2013 Mar 1.
5
Skp2 is a promising therapeutic target in breast cancer.
Front Oncol. 2012 Jan 4;1(57). doi: 10.3389/fonc.2011.00057.
6
Novel roles of Skp2 E3 ligase in cellular senescence, cancer progression, and metastasis.
Chin J Cancer. 2012 Apr;31(4):169-77. doi: 10.5732/cjc.011.10319. Epub 2011 Dec 23.
7
Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK.
Oncogene. 2012 Sep 13;31(37):4128-38. doi: 10.1038/onc.2011.570. Epub 2011 Dec 12.
8
The 26S proteasome complex: an attractive target for cancer therapy.
Biochim Biophys Acta. 2012 Jan;1825(1):64-76. doi: 10.1016/j.bbcan.2011.10.003. Epub 2011 Oct 18.
9
Skp2: a novel potential therapeutic target for prostate cancer.
Biochim Biophys Acta. 2012 Jan;1825(1):11-7. doi: 10.1016/j.bbcan.2011.09.002. Epub 2011 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验